During the past decade, Texas Eye Research Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Eye Research Center" #1 sponsor was "Johnson & Johnson Surgical Vision, Inc." with 2 trials, followed by "AMO Development, LLC" with 1 trials sponsored, "Alcon Research" with 1 trials sponsored, "Noveome Biotherapeutics, formerly Stemnion" with 1 trials sponsored and "RxSight, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Eye Research Center" #1 collaborator was "IQVIA Biotech" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Texas Eye Research Center" are "Cataract" (2 trials), "Aphakia" (1 trials), "Corneal Astigmatism" (1 trials), "Meibomian Gland Dysfunction" (1 trials) and "Persistent Corneal Epithelial Defect" (1 trials). Many other conditions were trialed in "Texas Eye Research Center" in a lesser frequency.

Most popular intervention types in "Texas Eye Research Center" are "Device" (5 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "0.67% Sodium Chloride Ophthalmic Solution" (1 trials), "Activator LFD-2100" (1 trials), "Cataract surgery" (1 trials), "Control IOL" (1 trials) and "Higher Cylinder Toric IOL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Texas Eye Research Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Texas Eye Research Center". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Texas Eye Research Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Eye Research Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".